2014 Annual Meeting | 8MS.005 - Psychogenic Movement Disorders

Date Saturday 05/03/14

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Morning Seminar

Director(s) Aikaterini Kompoliti, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to describe the clinical phenomenology, epidemiology, and clinical impact of psychogenic movement disorders; recognize other conditions that share features in common with psychogenic movement disorders and could be mistakenly identified as psychogenic; and develop a practical approach to the examination, diagnosis, and treatment of psychogenic movement disorders.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
06:30 AM - 06:50 AM		Diagnosis and Phenomenology Aikaterini Kompoliti, MD, FAAN
06:50 AM - 07:10 AM		Epidemiology and Investigation Vanessa K. Hinson, MD, PhD, FAAN
07:10 AM - 07:30 AM		Presenting the Diagnosis and Prognosis Aikaterini Kompoliti, MD, FAAN
07:30 AM - 07:50 AM		Treatment Vanessa K. Hinson, MD, PhD, FAAN
07:50 AM - 08:00 AM		Discussion, Case Presentation Vanessa K. Hinson, MD, PhD, FAAN, Aikaterini Kompoliti, MD, FAAN

Faculty Disclosures
Aikaterini Kompoliti, MD, FAAN	Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kompoliti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scion. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Kompoliti has received research support from Emalex. Dr. Kompoliti has received research support from TEVA. Dr. Kompoliti has received research support from Theravance. Dr. Kompoliti has received research support from Ipsen. Dr. Kompoliti has received research support from Theravance.
Vanessa K. Hinson, MD, PhD, FAAN	The institution of Dr. Hinson has received research support from Biogen. The institution of Dr. Hinson has received research support from Scion Neurostim. The institution of Dr. Hinson has received research support from PPD Development/Takeda Development. The institution of Dr. Hinson has received research support from Parexel Biopharma. The institution of Dr. Hinson has received research support from Impax Laboratories.

��ɫ��

��ɫ��